Abstract
Summary
KEY FINDINGS
The India cough syrup market is estimated to develop with a CAGR of 3.52% during the forecast period. The country’s market growth is primarily attributed to the rising incidence of chronic respiratory diseases in addition to the increasing levels of air pollution. While the base year considered for the market studied is 2020, the projected years are from 2021 to 2026.
MARKET INSIGHTS
Cough syrups play a vital role in suppressing and loosening mucus in the airways that help clear the congestion and thus, make breathing easier. They also help with allergic symptoms such as sneezing, runny nose, watery eyes, as well as throat irritation. Moreover, some combination cough syrups relieve coughs caused by the common cold, various breathing illnesses, and bronchitis.
The surging population of India is accredited to the increasing pollution levels, primarily due to the felling of trees to widen roads, the use of private cars, and the construction of new housing and public infrastructure. As per the Greenpeace Southeast Asia Analysis of IQAir, more than 120,000 people in India died in the year 2020 on account of air pollution and other associated problems. Household air pollution is widespread in the country, linked to a heightened risk of tuberculosis, obstructive lung diseases, asthma, and others. As a result, factors such as the increasing air pollution and the rising prevalence of respiratory disorders mainly fuel the cough syrup market growth in India.
COMPETITIVE INSIGHTS
Key players operating in the market are Dabur India Ltd, Cipla Ltd, The Himalaya Drug Company, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
1 RESEARCH SCOPE & METHODOLOGY
1.1 STUDY OBJECTIVES
1.2 SCOPE OF STUDY
1.3 METHODOLOGY
1.4 ASSUMPTIONS & LIMITATIONS
2 EXECUTIVE SUMMARY
2.1 MARKET SIZE & ESTIMATES
2.2 COUNTRY SNAPSHOT
2.3 COUNTRY ANALYSIS
2.4 KEY GROWTH ENABLERS
2.5 KEY CHALLENGES
3 KEY ANALYTICS
3.1 IMPACT OF COVID-19 ON COUGH SYRUP MARKET
3.2 KEY MARKET TRENDS
3.3 PORTER’S FIVE FORCES ANALYSIS
3.3.1 BUYERS POWER
3.3.2 SUPPLIERS POWER
3.3.3 SUBSTITUTION
3.3.4 NEW ENTRANTS
3.3.5 INDUSTRY RIVALRY
3.4 OPPORTUNITY MATRIX
4 MARKET BY PRODUCT TYPE
4.1 COUGH SUPPRESSANTS/ANTITUSSIVES
4.2 COMBINATION MEDICATIONS
4.3 EXPECTORANTS
5 MARKET BY AGE GROUP
5.1 ADULT
5.2 PEDIATRIC
6 MARKET BY DISTRIBUTION CHANNELS
6.1 RETAIL PHARMACY
6.2 HOSPITAL PHARMACY
6.3 ONLINE PHARMACY
7 COMPETITIVE LANDSCAPE
7.1 KEY STRATEGIC DEVELOPMENTS
7.1.1 MERGERS & ACQUISITIONS
7.1.2 PARTNERSHIPS & AGREEMENTS
7.2 COMPANY PROFILES
7.2.1 CIPLA LIMITED
7.2.2 DABUR INDIA LTD
7.2.3 GLENMARK PHARMACEUTICAL LIMITED
7.2.4 JOHNSON & JOHNSON
7.2.5 THE HIMALAYA DRUG COMPANY